QIAxcel — increasing productivity in genotyping applications

We are excited to have Dr. Carola Schade presenting a one-hour webinar (including Q&A) about how the QIAxcel system can increase productivity in genotyping and genetic testing laboratories. This webinar focuses on the challenges of typical genotyping applications and describes possible solutions for these, covering aspects from sample purification to detection of end-point PCR products using the QIAxcel system.

The most commonly used method for analysis of genotyping assays based on end-point PCR is gel electrophoresis, using manually poured slab gels. This method is extremely labor intensive and exposes users to hazardous chemicals such as ethidium bromide. In addition, resolution of such gels is often poor and detailed analysis of the data in terms of determination of fragment size can be tedious — especially when the data are to be compared with previously analyzed PCR products.

The QIAxcel replaces traditional, labor-intensive agarose gel electrophoresis and reduces time to results. With ready-to-run gel cartridges, the QIAxcel fully automates sensitive, high-resolution capillary electrophoresis of up to 96 samples per run. DNA fragments are resolved down to 3–5 bp, with minimal hands on interaction, reduced handling errors, and maximum ease of use.

Dr. Carola Schade

Carola Schade
Dr. Carola Schade joined QIAGEN in 1999. She is involved in developing automated solutions for sample purification and analysis and introducing them to the global marketplace. She currently holds the position of Director, Head of Instruments Business Life Science. Carola studied at the Heinrich-Heine University of Düsseldorf where she obtained her PhD in Biology at the Institute for Molecular Genetics.